NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Published facts

What the notice says

Buyer

NHS England

Published status

complete

Latest release reference

068603-2026

CPV codes

Common Procurement Vocabulary (CPV) codes: 33600000

Published tags

award, contract

Latest record Bidwake loaded from this source

27 Aug 2026

NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Open the official Find a Tender notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

1. Planning notice observed

   22 May 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   024471-2025

   Published tags

   planning

2. Planning record updated

   3 Jun 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   029473-2025

   Published tags

   planningUpdate

3. Planning notice observed

   13 Jan 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   002508-2026

   Published tags

   planning

4. Planning record updated

   13 Mar 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

Awards and suppliers

Published award and contract facts

• NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

  Buyer: NHS EnglandSupplier: Accord UK Ltd

  End date in notice

  31 Aug 2028Date from the linked contract

  Value shown in notice

  £665,389,588Value from the linked contract

  Official source

  Open the official Find a Tender notice for NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

  About this figure

  • This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
  • This figure comes from the linked contract record. Overall totals continue to use the separately published award value.

  View record references

  Source

  Find a Tender

  Award or lot reference

  3

• NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

  Buyer: NHS EnglandSupplier: Amgen Ltd

Related evidence

Published terms and linked processes

• Renewal information is statedLot 1Repeated in 4 notices; the most recent statement is shown.Published 13 Mar 2026.Open supporting notice 023102-2026
• Options are statedLot 1

  CM/PHR/25/5730/01 – Lot 1 – Tranche A for North of England and Midlands & East 01/09/2026 – 31/08/2028 (24 Months) with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

  Published 17 Mar 2026.Open supporting notice 023990-2026
• Renewal information is statedLot 1

  With an option or option(s) to extend for a further 24 months.

  Published 17 Mar 2026.Open supporting notice 023990-2026
• Options are statedLot 2

  CM/PHR/25/5730/01 – Lot 1 – Tranche A for North of England and Midlands & East 01/09/2026 – 31/08/2028 (24 Months) with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

  Published 17 Mar 2026.Open supporting notice 023990-2026
• Renewal information is statedLot 2

  With an option or option(s) to extend for a further 12 months.

  Published 17 Mar 2026.Open supporting notice 023990-2026

No exact source-published process relationship was found.